High Content Screening Market By Product (Instruments, Consumables, Software, Services, Accessories), By Application (Target Identification And Validation, Primary Screening And Secondary Screening, Toxicity Studies, Compound Profiling) - Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025
Global High Content Screening Market by Products (Instruments, Consumables, Software, Services and Accessories) by Applications (Target Identification and Validation, Primary Screening and Secondary Screening, Toxicity Studies, Compound Profiling and Others) - Market Growth, Future Prospects & Competitive Analysis, 2017 – 2025.
High content screening is the most established approach for the multi parametric analysis of cellular events for e.g. the citation 5 cell imaging multi-mode reader combines the automated digital wide field microscopy with conventional multimode microplate reading and can capture the qualitative information regarding the phenotypic cellular information in a single experiment. It has undergone tremendous technological advancements overt the last decade, HCS imaging systems is expected to evolve continuously throughout the forecast period to offer greater flexibility and requirement of assays involving complex cellular disease models. High content screening has rising demands for the analysis of 3D spheroids/microtissues and phenotypic assays, it will have a huge impact in the near future in gene editing studies based on CRISP-Cas9.
For the purpose of this study, the various products studied includes instruments, consumables, software, services and accessories. The applications are classified as target identification and validation, primary screening and secondary screening, toxicity studies, compound profiling and others. Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
The geographic segmentation of the global high content screening market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global high content screening market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global high content screening market. The key players profiled in this report are Becton Dickinson and Company, Bio-Rad Laboratories, BioTek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore Corporation, Olympus Corporation, Perkin Elmer, Inc., Tecan Group and Yokogawa Electric Corporation.
Based on product, the global high content screening market is categorized into
- Instruments
- Cell Imaging and Analysis System
- Flow Cytometers
- Consumables
- Reagents and Assay kits
- Microplates
- Other Consumables
- Software
- Services
- Accessories
The high content screening market is driven by factors such as rising need for cost containment in the pharmaceutical research and development and enhanced funding in proteomics. In addition the technological advancement in the techniques employed such as flow cytometry, automated imaging technology and use of multicolored fluorescence based reagents will propel the deep market penetration for high content screening. In 2016, instrument segment held the largest market share chiefly due to factors such as technological advancement in the automation techniques, phenotypic screening and finds huge application in biopharmaceuticals, contract research organization, and research institutes etc. Software will be the fastest growing market throughout the forecast period 2017-2025 majorly due to its application in obtaining multi-parametric analysis of cellular events, assists in obtaining image processing and visualization tools to extract quantitative data from cell population. The major players in high content screening market are Becton Dickinson and Company, Bio-Rad Laboratories, BioTek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore Corporation, Olympus Corporation, Perkin Elmer, Inc., Tecan Group and Yokogawa Electric Corporation.
Based on application, the global high content screening market is categorized into
- Target Identification and Validation
- Primary Screening and Secondary Screening
- Toxicity Studies
- Compound Profiling
- Others
The high content screening is witnessing tremendous growth significantly due to increasing need to launch novel drug molecules owing to the presence of outdated drug therapy regimen with ineffective pharmacodynamic profile. Additionally the burgeoning requirement to promote intensive treatment of chronic diseases such as cardiovascular complications, diabetes, Alzheimer’s, Parkinson’s, cancer, etc. Drug toxicity screening is necessary for new drug application (NDA) and clinical trial approval before the drug enters the market. In 2016, target identification and validation and primary and secondary screening both dominated the market mainly due to factors such as increasing number of biosimilars and biological drug candidates in the market requiring primary and secondary screening to prove drug efficacy and safety. Additionally the Hope Act (2013) signed by US government to encourage the development of novel therapies for children with rare diseases will employ target identification and validation to determine the approach for drug discovery and development. The toxicity studies segment is anticipated to register faster growth throughout the forecast period 2017-2025, majorly due to rising incidence of drug related adverse events, increased risk associated with the toxic metabolites produced by the drug biotransformation process, and stringent regulatory norms by USFDA to enhance the drug toxicity screening in the drug clinical trial phase.
For the purpose of this study, the global high content screening market is categorized into the following regional and country specific markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
North America was observed to be the largest market for high content screening in the base year 2016. The dominance of North America is mainly attributed to the presence of key pharmaceutical players focusing on novel drug discovery and enhanced government spending in the research and development facilities in healthcare institutions. The market growth in Europe is mainly attributed to the increasing number of patients suffering with rare diseases such as Gaucher disease, Pompe disease or multiple sclerosis. This factor boosts the demand for phenotypic drug screening and technological advancement in the instruments employed for image analysis and data collection for cellular activities. Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are presence of large patient pool which can be enrolled to study drug toxicity studies for drug clinical trials, competitive market due to presence of existing major players and evolving biopharmaceutical and medical imaging manufacturers in these regions, and supportive regulatory environment for high content screening products. Moreover, factors such as developing health infrastructure, public private partnership between major pharma players and government agencies are going to fuel the rapid growth of high content screening market in Latin America, and Middle East and Africa region in the near future.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global High Content Screening Market Portraiture
2.1.1. Global High Content Screening Market, by Product, 2016
2.1.2. Global High Content Screening Market, by Application, 2016
2.1.3. Global High Content Screening Market, by Geography, 2016
Chapter 3. High Content Screening Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global High Content Screening Market, by Product
4.3. Instruments
4.3.1. Cell Imaging and Analysis System
4.3.2. Flow Cytometers
4.4. Consumables
4.4.1. Reagents and Assay Kits
4.4.2. Microplates
4.4.3. Other Consumables
4.5. Software
4.6. Services
4.7. Accessories
Chapter 5. Global High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global High Content Screening Market, by Application
5.3. Target Identification and Validation
5.4. Primary Screening and Secondary Screening
5.5. Toxicity Studies
5.6. Compound Profiling
5.7. Others
Chapter 6. Global High Content Screening Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America High Content Screening Market Analysis, 2015 – 2025
6.2.1. North America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe High Content Screening Market Analysis, 2015 – 2025
6.3.1. Europe High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Rest of Europe
6.4. Asia Pacific High Content Screening Market Analysis, 2015 – 2025
6.4.1. Asia Pacific High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America High Content Screening Market Analysis, 2015 – 2025
6.5.1. Latin America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) High Content Screening Market Analysis, 2015 – 2025
6.6.1. MEA High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. MEA High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA High Content Screening Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Becton Dickinson and Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bio-Rad Laboratories, Inc.
7.3. BioTek Instruments, Inc.
7.4. Danaher Corporation
7.5. GE Healthcare
7.6. Merck Millipore Corporation
7.7. Olympus Corporation
7.8. Perkin Elmer, Inc.
7.9. Tecan Group
7.10. Yokogawa Electric Corporation
TABLE 1 Global High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Instruments Market, 2015 – 2025 (US$ Mn)
TABLE 3 Global Consumables Market, 2015 – 2025 (US$ Mn)
TABLE 4 Global High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 5 Global High Content Screening Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 7 North America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 8 North America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 11 Europe High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa High Content Screening Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 21 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 BioTek Instruments, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Olympus Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Perkin Elmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Tecan Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Yokogawa Electric Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 High Content Screening: Market Segmentation
FIG. 2 Global High Content Screening Market Share, by Product, 2016 (Value %)
FIG. 3 Global High Content Screening Market Share, by Application, 2016 (Value %)
FIG. 4 Global High Content Screening Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Cell Imaging and Analysis System Market 2015 – 2025 (US$ Mn)
FIG. 8 Global Flow Cytometers Market 2015 – 2025 (US$ Mn)
FIG. 9 Global Reagents and Assay Kits Market 2015 – 2025 (US$ Mn)
FIG. 10 Global Microplates Market 2015 – 2025 (US$ Mn)
FIG. 11 Global Other Consumables High Content Screening Market 2015 – 2025 (US$ Mn)
FIG. 12 Global Software Market 2015 – 2025 (US$ Mn)
FIG. 13 Global Services Market 2015 – 2025 (US$ Mn)
FIG. 14 Global Accessories Market 2015 – 2025 (US$ Mn)
FIG. 15 Global Target Identification and Validation Market 2015 – 2025 (US$ Mn)
FIG. 16 Global Primary Screening and Secondary Screening Market 2015 – 2025 (US$ Mn)
FIG. 17 Global Toxicity Studies Market 2015 – 2025 (US$ Mn)
FIG. 18 Global Compound Profiling Market 2015 – 2025 (US$ Mn)
FIG. 19 Global Others High Content Screening Application Market 2015 – 2025 (US$ Mn)
FIG. 20 U.S. High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 21 Canada High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 22 U.K. High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 23 Germany High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 24 France High Content Screening Market, 2015-2025 (US$ Mn)
FIG. 25 Rest of Europe High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 26 Japan High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 27 China High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 28 India High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 29 Rest of Asia Pacific High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 30 Brazil High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 31 Mexico High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 32 Rest of Latin America High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 33 GCC High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Middle East and Africa High Content Screening Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)